Valuation check: NVACR's ROE is 142.73%, above the sector sector average of -5.72%.
Get informed when a big investor buys or sells
+ Follow142.73%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
NorthView Acquisition - Tradeable Rights - Aug 2027's return on equity stands at 142.73%. That is above the sector sector average of -5.72%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
NorthView Acquisition - Tradeable Rights - Aug 2027 sits higher the its sector benchmark (-5.72%) with a ROE of 142.73%. That is roughly 2594.2% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A ROE of 142.73% for NorthView Acquisition - Tradeable Rights - Aug 2027 means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how NorthView Acquisition - Tradeable Rights - Aug 2027's ROE evolved across reporting periods, while the comparison chart places NVACR next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.